Since the 1930s, doctors have successfully treated various forms of skin cancer, including basal cell carcinoma and squamous cell carcinoma, the most common forms of skin cancer, using Mohs micrographic surgery. Today, Mohs surgery is the most widely accepted and utilized treatment for skin cancer with cure rates of over 98%. However, there are many downsides to Mohs surgery. Because the estimation of how much tissue that needs to be removed to excise the skin cancer cells occurs during the operation, there is no for sure answer of how deep into the skin surgeons must cut and how long the procedure will last. In cases of deeply rooted cancers, patients can be stuck with disfiguring scars requiring reconstructive plastic surgery and lengthy recovery periods. Additionally, many patients diagnosed with basal cell or squamous cell carcinoma are of an age where diabetes, heart disease, and other medical conditions can lead to serious complications during surgery. Luckily, there is another solution for the treatment of non-melanoma skin cancers like basal cell and squamous cell carcinoma.
The Benefits of SRT
Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:
- 95%+ cure rates that rival surgery
- No anesthesia, cutting, bleeding, stitching or pain
- No downtime or lifestyle restrictions
- Super cosmesis, no unsightly scarring
- No need for post-treatment reconstructive surgeries